Jeffrey V. Lazarus
PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain / CUNY Graduate School of Public Health and Health Policy, United States
Related Materials
The Innovations in NAFLD Care (INCBCN) Workshop 2023 took place as a hybrid workshop in Barcelona, Spain, from 26-27 May 2023. Delegates were able to attend either in person in Barcelona or virtually from their computer.
This workshop was the third meeting in the Innovations in NAFLD Care Series. The second was the Innovations in NAFLD Care Webinar 2022, held on 6 May 2022 - 7 May 2022.
Non-alcoholic fatty liver disease (NAFLD) is estimated to affect 33% of the world’s population. Given the association between NAFLD and the growing global epidemics of obesity and type 2 diabetes, this number is expected to increase. Despite this high prevalence, there remain challenges in screening, as only a minority of cases are diagnosed and correctly treated. Therefore, there is a growing need to design and implement comprehensive models of care. The cascade of care for the diagnosis and treatment of NAFLD requires a multidisciplinary approach, with the development of patient-centric structures and systems that facilitate the coordination and integration of services delivered at different levels of healthcare systems.
This workshop provides a platform to bring together the relevant stakeholders and patients to optimize NAFLD care.
The 2-day program explores the different perspectives that healthcare professionals and patients with NAFLD face daily. It will highlight where healthcare providers and policy-makers can implement the most comprehensive models of NAFLD care.
The NASH-NITs Real-World-Evidence Summit featured state-of-the-art lectures on the use of real-world evidence for the proper diagnosis of NASH using NITs. The summit was hosted in Barcelona on 26 May as a pre-workshop to the 2nd edition of the “Innovations in NAFLD Care workshop”. The summit was a half-day hybrid summit, where ample time was reserved for debates and panel discussions to exchange knowledge and reinforce the implementation of real-world evidence for the screening, identification, and diagnosis of NAFLD/NASH.
PhD, MIH, MA
Barcelona Institute for Global Health (ISGlobal), Spain / CUNY Graduate School of Public Health and Health Policy, United States
MD
Saarland University Medical Center, Germany
MD, FACP, FACE
The University of Florida, United States
MD, FAASLD
University of Chicago Medicine, United States
MD, MSc, FEBTM, FRCP, PhD
Royal Free Hospital, United Kingdom
BSc, RD, PhD
University of Haifa / The Tel-Aviv Medical Center, Israel